- Home
- Industry Reports
- Healthcare
- Medical Devices
- South Korea Neurology Devices Market- Size, Outlook, Trends and Forecast (2024 – 2032)
Neurology is a branch of medicine that deals with the disorders of the nervous system and deals with the diagnosis and treatment of diseases involving central and peripheral nervous system. Neurological devices such as ventricular needles, neurostimulators, and blood clot retrievers can prevent neurological disorders and can be used to restore hearing and sight. The market share is estimated to reach USD XX billion with a CAGR of XX% by 2024.
South Korea Neurology Devices Market Share:
Compared to the past years, Neurology devices have undergone a predominant change in the markets of Sweden. The Neurostimulation devices are expected to have the highest growth rate due to the increasing number of ageing population, advancement in technology and growing demand for the medical procedures.
South Korea Neurology Devices Market Size:
There is a wide range of fields in which these Neurology Devices are used such as Interventional Neurology Devices, and this is subcategorised into Cerebral Balloon Devices, Neurothrombectomy Devices, Neurosurgery Devices. As there are significant applications, the market size related to Neurology Devices is, even more, more significant in Sweden.
South Korea Neurology Devices Market Growth:
The factors that drive the growth of the market are increasing in respiratory disease population, growing number of stroke and cerebral aneurysms cases and rising disposable incomes coupled with a change in lifestyle. Tax reform is the primary factor that prevents the growth of the market.
South Korea Neurology Devices Market Industry Analysis:
Sweden Neurology Devices Market is segmented based on neurology devices which are further classified into interventional neurology devices, cerebral balloon devices, Neurothrombectomy devices, neurosurgery devices, aneurysm coiling & embolisation and Neurostimulation devices.
South Korea Neurology Devices Market Outlook:
Due to the growth of health consciousness among people, an ageing population, increase in hospital number, demand for the hospital supplies, the growth of different types of dreadful diseases has led hospital supplies to have a higher outlook where the market parameters and marginal values are taken into consideration.
South Korea Neurology Devices Market Trends:
Johnson & Johnson acquired Actelion Pharmaceuticals on Jan 26th, 2017. Penumbra Inc bought all the outstanding shares of crossed S.p.a a joint stack company on July 3rd, 2017.
South Korea Neurology Devices Market Research Report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Penumbra, Inc.
- Boston Scientific Corporation
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type
6.1 Neurology Devices
6.1.1 By Type of Device
6.1.1.1 Cerebrospinal Fluid Management Devices
6.1.1.1.1 Cerebral External Drainage
6.1.1.1.2 Cerebral Shunts
6.1.1.2 Interventional Neurology Devices
6.1.1.2.1 Neurothrombectomy Devices
6.1.1.2.1.1 Snare Devices
6.1.1.2.1.2Suction Aspiration Devices
6.1.1.2.1.3 Clot Retrievers
6.1.1.2.2 Cerebral Balloon Devices
6.1.1.2.2.1 Filter Devices
6.1.1.2.2.2 Balloon Occlusion Devices
6.1.1.2.2.3 Carotid Artery
6.1.1.2.3 Aneurysm Coiling & Embolization
6.1.1.2.3.1 Liquid Embolic Agents Embolic Coils
6.1.1.2.3.2 Flow Diversion Devices Liquid Embolic Agents
6.1.1.2.3.3 Embolic Coils
6.1.1.2.4 Support Devices
6.1.1.3 Neurosurgery Devices
6.1.1.3.1 Ultrasonic Aspirators Neuroendoscopes
6.1.1.3.2 Neuroendoscopes Stereotactic Systems
6.1.1.3.3 Stereotactic Systems Aneurysm Clips
6.1.1.3.4 Aneurysm Clips
6.1.1.4 Neurostimulation Devices
6.1.1.4.1 Deep Brain Stimulation Devices
6.1.1.4.2 Sacral Nerve Stimulation Devices
6.1.1.4.3 Spinal Cord Stimulation Devices
6.1.1.4.4 Vagus Nerve Stimulation Devices
6.1.1.4.5 Gastric Electric Stimulation Devices
Chapter 7 Market Segmentation by geography
7.1 Introduction
7.2 South Korea
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Strategies Adopted by Top Companies
8.3 Market Share Analysis
Chapter 9 Company Profiles
9.1 Stryker Corporation
9.1.1 Introduction
9.1.2 Company overview
9.1.3 Financial Performance
9.1.4 Product Benchmarking
9.2 Johnson & Johnson
9.3 Terumo Corporation
9.4 Penumbra, Inc.
9.5 Boston Scientific Corporation
9.6 Microport Scientific Corporation
9.7 Merit Medical Systems, Inc.
9.8 W.L. Gore & Associates, Inc
9.9 Abbott Laboratories
9.10 BTG plc
9.11 Braun Melsungen AG
9.12 Integra Lifesciences Corp.
9.13 DePuy Synthes Inc
9.14 Bioforce SA (Pty) Ltd
9.15 Byk Madus (Pty) Ltd
Chapter 10 Market Estimates and Forecast
10.1 Market Estimation and Forecast 2018-2024(USD Billion)
10.1.1 Market Estimates and Forecast by Type 2018-2024 (USD Billion)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Billion)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Investment Opportunities
11.3 Analyst Opinion
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Country Report
$1,800.00 – $5,400.00
- EUR: €1,656.54 - €4,969.63
- INR: ₹150,298.18 - ₹450,894.53
- AED: د.إ6,606.00 - د.إ19,818.00
- GBP: £1,422.14 - £4,266.43
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Neurology is a branch of medicine that deals with the disorders of the nervous system and deals with the diagnosis and treatment of diseases involving central and peripheral nervous system. Neurological devices such as ventricular needles, neurostimulators, and blood clot retrievers can prevent neurological disorders and can be used to restore hearing and sight. The market share is estimated to reach USD XX billion with a CAGR of XX% by 2024.
South Korea Neurology Devices Market Share:
Compared to the past years, Neurology devices have undergone a predominant change in the markets of Sweden. The Neurostimulation devices are expected to have the highest growth rate due to the increasing number of ageing population, advancement in technology and growing demand for the medical procedures.
South Korea Neurology Devices Market Size:
There is a wide range of fields in which these Neurology Devices are used such as Interventional Neurology Devices, and this is subcategorised into Cerebral Balloon Devices, Neurothrombectomy Devices, Neurosurgery Devices. As there are significant applications, the market size related to Neurology Devices is, even more, more significant in Sweden.
South Korea Neurology Devices Market Growth:
The factors that drive the growth of the market are increasing in respiratory disease population, growing number of stroke and cerebral aneurysms cases and rising disposable incomes coupled with a change in lifestyle. Tax reform is the primary factor that prevents the growth of the market.
South Korea Neurology Devices Market Industry Analysis:
Sweden Neurology Devices Market is segmented based on neurology devices which are further classified into interventional neurology devices, cerebral balloon devices, Neurothrombectomy devices, neurosurgery devices, aneurysm coiling & embolisation and Neurostimulation devices.
South Korea Neurology Devices Market Outlook:
Due to the growth of health consciousness among people, an ageing population, increase in hospital number, demand for the hospital supplies, the growth of different types of dreadful diseases has led hospital supplies to have a higher outlook where the market parameters and marginal values are taken into consideration.
South Korea Neurology Devices Market Trends:
Johnson & Johnson acquired Actelion Pharmaceuticals on Jan 26th, 2017. Penumbra Inc bought all the outstanding shares of crossed S.p.a a joint stack company on July 3rd, 2017.
South Korea Neurology Devices Market Research Report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Penumbra, Inc.
- Boston Scientific Corporation
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type
6.1 Neurology Devices
6.1.1 By Type of Device
6.1.1.1 Cerebrospinal Fluid Management Devices
6.1.1.1.1 Cerebral External Drainage
6.1.1.1.2 Cerebral Shunts
6.1.1.2 Interventional Neurology Devices
6.1.1.2.1 Neurothrombectomy Devices
6.1.1.2.1.1 Snare Devices
6.1.1.2.1.2Suction Aspiration Devices
6.1.1.2.1.3 Clot Retrievers
6.1.1.2.2 Cerebral Balloon Devices
6.1.1.2.2.1 Filter Devices
6.1.1.2.2.2 Balloon Occlusion Devices
6.1.1.2.2.3 Carotid Artery
6.1.1.2.3 Aneurysm Coiling & Embolization
6.1.1.2.3.1 Liquid Embolic Agents Embolic Coils
6.1.1.2.3.2 Flow Diversion Devices Liquid Embolic Agents
6.1.1.2.3.3 Embolic Coils
6.1.1.2.4 Support Devices
6.1.1.3 Neurosurgery Devices
6.1.1.3.1 Ultrasonic Aspirators Neuroendoscopes
6.1.1.3.2 Neuroendoscopes Stereotactic Systems
6.1.1.3.3 Stereotactic Systems Aneurysm Clips
6.1.1.3.4 Aneurysm Clips
6.1.1.4 Neurostimulation Devices
6.1.1.4.1 Deep Brain Stimulation Devices
6.1.1.4.2 Sacral Nerve Stimulation Devices
6.1.1.4.3 Spinal Cord Stimulation Devices
6.1.1.4.4 Vagus Nerve Stimulation Devices
6.1.1.4.5 Gastric Electric Stimulation Devices
Chapter 7 Market Segmentation by geography
7.1 Introduction
7.2 South Korea
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Strategies Adopted by Top Companies
8.3 Market Share Analysis
Chapter 9 Company Profiles
9.1 Stryker Corporation
9.1.1 Introduction
9.1.2 Company overview
9.1.3 Financial Performance
9.1.4 Product Benchmarking
9.2 Johnson & Johnson
9.3 Terumo Corporation
9.4 Penumbra, Inc.
9.5 Boston Scientific Corporation
9.6 Microport Scientific Corporation
9.7 Merit Medical Systems, Inc.
9.8 W.L. Gore & Associates, Inc
9.9 Abbott Laboratories
9.10 BTG plc
9.11 Braun Melsungen AG
9.12 Integra Lifesciences Corp.
9.13 DePuy Synthes Inc
9.14 Bioforce SA (Pty) Ltd
9.15 Byk Madus (Pty) Ltd
Chapter 10 Market Estimates and Forecast
10.1 Market Estimation and Forecast 2018-2024(USD Billion)
10.1.1 Market Estimates and Forecast by Type 2018-2024 (USD Billion)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Billion)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Investment Opportunities
11.3 Analyst Opinion
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.